Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

Greece suspends rollout of J&J vaccine for COVID-19

2 minute read

Johnson & Johnson's coronavirus disease (COVID-19) vaccines are seen at Northwell Health's South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton/File Photo

ATHENS, April 19 (Reuters) - Greece has suspended a planned rollout of Johnson & Johnson's (JNJ.N) COVID-19 vaccinations but does not expect that to impact its overall inoculation programme, authorities said on Monday.

Greece had been expected to start Johnson & Johnson vaccinations on Monday before questions emerged over reports of very rare blood clotting disorders associated with the use of the vaccine.

Several countries have suspended or restricted use of the J&J vaccine as well as an AstraZeneza shot after European and British regulators confirmed possible links to rare blood clots.

The head of the national vaccination committee, Maria Theodoridou, said Greece would wait until the European Medicines Agency (EMA) announced its review of the issue on Tuesday.

Greece has received 33,600 doses of the J&J vaccines, the secretary general in charge of vaccinations, Marios Themistocleous, told a regular briefing.

J&J vaccinations were "most likely to start in May," he said.

Reporting by Karolina Tagaris

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters